HKIB Advanced Therapy Products (ATP) GMP Centre is a state-of-the-art facility that upholds the PIC/S GMP Standard to ensure the highest quality and international compliance. Our manufacturing solutions aim to serve the distinctive needs of academic and non-academic partners. With our expertise, we are committed to support you through every stage, from clinical trials to commercial scale production.


HKIB Advanced Therapy Products (ATP) Good Manufacturing Practice (GMP) Centre designed to comply with PIC/S GMP Standard officially opened in 2023. The facility is designed for cell and gene therapy product manufacturing and multiple Advanced Therapy Products (ATP) processes.

The centre offers academic and non-academic collaborators flexible manufacturing solutions without the capital investment of building its own.

The operation gives acceleration of clinical trials to commercial scale production and offers certainty of manufacturing future. The centre has a highly-skilled workforce, cluster development and excellent logistics infrastructure. Collaborators can access segregated modules to manufacture their own products.

The facility has 6 operationally segregated cleanrooms, in-house quality control laboratory, and designated process development centre. Expansion plan is underway.

The Hong Kong Institute Of Biotechnology

  • Founded in 1988, through Hong Kong Jockey Club donation.
  • Non-Profit Organization, wholly owned by The Chinese University of Hong Kong.
  • Also a research institute of The Chinese University of Hong Kong.
  • Appointed by Innovation and Technology Commission as a designated local public research institute in Hong Kong.
  • Visit HKIB: